top of page
CET is partnering with the John Paul II Medical Research Institute (JP2MRI) to recruit patients around the country to develop patient and disease-specific stem cells and human non-stem cells for novel, targeted preclinical drug discovery. The Institute collaborates with several hospitals, medical practices and private foundations to recruit patients with a variety of diseases.
CET currently partners with JP2MRI to recruit patients to develop patient and disease-specific cell models.
bottom of page